Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical markets. It primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its soft tissue repair products include, among other products, the lead product, CellerateRX Surgical Powder, a hydrolyzed collagen that aids in the management of surgical wounds, BIASURGE Advanced Surgical Solution, a sterile no-rinse, advanced surgical solution used for wound irrigation and TEXAGEN Amniotic Membrane Allograft, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement if needed. Its bone fusion products include, among other products, BiFORM Bioactive Moldable Matrix, ACTIGEN Verified Inductive Bone Matrix, and ALLOCYTE Plus Advanced Viable Bone Matrix.
Company Information
About this company
Key people
Key facts
- Shares in issue9.19m
- EPICSMTI
- ISINUS79957L1008
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$322.87m
- Employees108
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.